From: Treatment of splenic trauma in Norway: a retrospective cohort study
All patients | OIS 1&2 | OIS 3 | OIS 4&5 | |
---|---|---|---|---|
Patients, n | 151a | 50 | 53 | 47 |
ISS, median (IQR) | 16 (9,24) | 13 (6,24) | 13 (9,22) | 17 (16,25) |
Transfusion ≥1 unit RBC, n (%) | 52 (34) | 10 (20) | 20 (38) | 22 (47) |
Length of stay in hospital (days), median (IQR) | 5 (2,10) | 4 (2,8) | 6 (4,11) | 6 (1,11) |
Length of stay in ICU or HDU (days), median (IQR) | 1.5 (1,3) | 1 (0,2) | 2 (1,4) | 1 (1,3) |
Non-operative treatment | ||||
Observation alone, n (%) | 108 (72)a | 47 (94) | 38 (72) | 22 (47) |
Angiography with or without embolization, n (%) | 20 (13) | 2 (4) | 7 (13) | 11 (23) |
Operative treatment | ||||
Splenectomy/spleen-preserving surgery, n/n (%) | 20/3 (15) | 0/1(2) | 7/1 (15) | 13/1 (30) |